The Efficacy of Vosevi in Treating DAA-experienced Patients

NCT06180590 · clinicaltrials.gov ↗

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C
Medication Reaction

Interventions

DRUG: Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi]

Sponsor

The Third Affiliated Hospital of Guangzhou Medical University